Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2005
12/07/2005CN1230525C Process for producing L-amino acid and novel gene
12/07/2005CN1230446C Antibodies and FV fragment recognizing antigen IORC2
12/06/2005US6972322 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972282 Process for producing a product containing antihypertensive tripeptides
12/06/2005US6972192 Polyhydroxyalkanoate synthase and gene encoding the same enzyme
12/06/2005US6972190 Polynucleotide with the activity of carbon starvation protein A (cstA); fermentative preparation of L-amino acids, such as L-lysine
12/06/2005US6972189 Microorganism producing frutosyl transferase and method for producing fructooligosaccharides and neofructooligosaccharides using the same
12/06/2005US6972186 Nucleic acid encoding pro 1410 polypeptides
12/06/2005US6972185 For use as pharmaceuticals, diagnostics, biosensors and bioreactors
12/06/2005US6972179 RRP sequences and knockout mice and uses thereof
12/06/2005US6972176 KVLQT1—a long QT syndrome gene
12/06/2005CA2201871C An enzyme and enzyme preparation with endoglucanase activity
12/06/2005CA2140683C Device for separating magnetically labelled cells
12/06/2005CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use
12/06/2005CA2013524C Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
12/01/2005WO2005113793A1 Method for introducing protein and/or peptide into cell
12/01/2005WO2005113776A2 Expression cassette
12/01/2005WO2005113772A1 Fluorescent protein
12/01/2005WO2005113766A1 Modified ethylenediamine-n,n’-disuccinic acid:ethylenediamine lyase
12/01/2005WO2005113746A1 Novel strain of bacillus as a bioinoculant
12/01/2005WO2005113745A1 Succinic acid-producing bacterium and process for producing succinic acid
12/01/2005WO2005113744A1 Succinic acid-producing bacterium and process for producing succinic acid
12/01/2005WO2005113583A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005WO2005112993A1 Vaccine for periodontal disease
12/01/2005WO2005112951A1 Antitumor agent, method of producing antitumor agent, medicinal composition containing antitumor agent and microorganism producing antitumor agent
12/01/2005WO2005112658A1 Method and composition for reducing e. coli disease and enhancing performance using bacillus
12/01/2005WO2005112629A2 Electrocompetent cells prepackaged for electroporation
12/01/2005WO2005091733A3 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
12/01/2005WO2005090589A3 Process for the production of l-amino acids using coryneform bacteria
12/01/2005WO2005082930A3 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
12/01/2005WO2005010794A3 Method for determining metabolic flux affecting substance production
12/01/2005WO2004104175A3 Probiotic bacteria and methods
12/01/2005WO2004070001A3 Assay and compositions for detection of bacillus anthracis nucleic acid
12/01/2005WO2004048552A3 Modulating immune responses
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050267298 Selected nucleotide sequences isolated from pathogenic strains of haemophilus influenzae
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050267025 Compositions and methods for treatment of infectious and inflammatory diseases
12/01/2005US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266545 Lactic acid bacteria with immunoregualting activites
12/01/2005US20050266543 Mixture comprising acid resistant glucoamylase for use in ethanol fermentation
12/01/2005US20050266541 Methods and compositions for evolving microbial hydrogen production
12/01/2005US20050266537 Process for producing poly-unsaturated fatty acids by oleaginous yeasts
12/01/2005US20050266536 Process for the fermentative preparation of L-amino acids using coryneform bacteria
12/01/2005US20050266534 Nucleotide sequences which code for the cstA gene
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266525 Expression control sequence
12/01/2005US20050266524 Beta integrin gene and protein
12/01/2005US20050266521 Production method for iturin a and its homologues
12/01/2005US20050266518 Comprises sequences coding hydroxymethylglutaryl-CoA reductase (HMG-COA reductase), isopentenyl diphosphate isomerase (IDI), mevalonate kinase, hydroxymethylglutaryl-CoA synthase (HMG-CoA synthase) for biosynthesis of zeaxanthin
12/01/2005US20050266517 Transformant containing transaldolase gene
12/01/2005US20050266486 Methods for treating obesity by inhibiting expression of obese gene product receptor variant
12/01/2005US20050266485 polynucleotides encoding a hematopoietic cytokine receptor polypeptide, for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs; test detecting a genetic disorder, cancer
12/01/2005US20050266484 gene therapy; a sequence which encodes the polypeptide podocin; proteinuria
12/01/2005US20050266479 Cloning, expression and characterization of the SPG4 gene responsible for the most common form of autosomal dominant spastic paraplegia
12/01/2005US20050266460 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
12/01/2005US20050266452 Novel human kinases and polynucleotides encoding the same
12/01/2005US20050266440 genetic engineered plants, whose cells are transfected with recombinant nucleic acid molecules that code a polyketide synthases for the production of polyunsaturated fatty acids (PUFAs); trangenic plants
12/01/2005US20050266436 thermostable mutants of B-type DNA polymerases comprising a Y-GG/A amino acid motif between the N-terminal 3'-5'-exonuclease domain and the C-terminal polymerase domain whereas the tyrosine of the Y-GG/A amino acid motif is mutated and whereas these mutant DNA polymerases are suitable for PCR.
12/01/2005US20050266431 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
12/01/2005US20050266394 Magnetophoretic cell clarification
12/01/2005US20050266017 Plasmodium falciparum antigens inducing protective antibodies
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265988 Glycosylated glucocerebrosidase expression in fungal hosts
12/01/2005US20050265987 Sulfatases and methods of use thereof
12/01/2005US20050265986 Sphingomyelinase compositions and use thereof
12/01/2005US20050265984 Weak assimilating activity or no assimilating activity for glycerol; beneficial bioactivities such as an intestine regulating activity and immunostimulating activity
12/01/2005US20050265975 Method for selective inactivation of viral replication
12/01/2005US20050262765 Floral packaging material having great masters prints thereon
12/01/2005DE102004052254A1 Verfahren zum Aufschluss von Zellen und zur Abtrennung von Zellbestandteilen A method of cell disruption and separation of cell components
12/01/2005DE102004023725A1 Verfahren zur Verkapselung bzw. Immobilisierung von Mikroorganismen Process for encapsulation or immobilization of microorganisms
12/01/2005DE102004022300A1 Multicomponent solid phase-submerged culture system, useful for preparation and testing of high performance strains for e.g. enzyme production or composting
12/01/2005DE102004017141A1 Neue Gene aus Biosynthese Genclustern zur Synthese von Aminoglycosid-Antibiotika sowie damit herstellbare neue Aminoglycosid-Antibiotika New genes from biosynthesis gene clusters for the synthesis of aminoglycoside antibiotics and thus producible new aminoglycoside antibiotics
12/01/2005CA2567501A1 An expression system comprising operably linked rgg gene and gtfg promoter
12/01/2005CA2567366A1 Methods for production of xylitol in microorganisms
12/01/2005CA2566617A1 Method and composition for reducing e.coli disease and enhancing performance using bacillus
12/01/2005CA2566585A1 Electrocompetent cells prepackaged for electroporation
12/01/2005CA2566363A1 High affinity ny-eso t cell receptor
12/01/2005CA2562911A1 Expression cassette
11/2005
11/30/2005EP1600512A1 mRNA purification on microplates
11/30/2005EP1600508A1 Novel vector
11/30/2005EP1600505A1 Escherichia coli phytase
11/30/2005EP1600501A1 Use of lif for tissue and cellular engineering
11/30/2005EP1600499A1 Process for producing lactonase and utilization thereof
11/30/2005EP1600458A1 Novel gene relating to fibrotic conditions
11/30/2005EP1600220A1 Additive for use in restoration of contaminated soil, ground water or sediment soil
11/30/2005EP1600135A1 Substrate for wood rotting
11/30/2005EP1599605A1 Screening method for genes of brewing yeast
11/30/2005EP1599601A1 Method for identification of novel virulence associated genes
11/30/2005EP1599596A2 Combinatorial dna library for producing modified n -glycans in lower eukaryotes
11/30/2005EP1599595A2 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/30/2005EP1599579A1 Translocating enzyme used as a selection marker
11/30/2005EP1599578A2 Methods for preventing gluconoylation of proteins
11/30/2005EP1599577A2 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response, tamoxifen resistance and metastasis
11/30/2005EP1599576A2 Methods for selecting medications
11/30/2005EP1599574A2 Biotransformation of compounds using non-prokaryotic microalgae
11/30/2005EP1599573A2 Model for studying the role of genes in tumor resistance to chemotherapy